TNF and infection: Indeed, in the nine randomised controlled trials that evaluated anti-TNF antibodies, 26 serious infections were reported among 1512 patients receiving placebo (incidence 1.7%).17 High-dose anakinra (⩾100 mg) seemed to increase the risk of serious infections.